Safety Study of Pritumumab in Brain Cancer

Clinical trial NCT04396717 · COMPLETED

Trial details

NCT number: NCT04396717
Sponsor: Nascent Biotech
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Primary Brain Tumors Brain Metastases, Adult

Start date: 2021-02-22
Primary completion: 2023-01-06
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.